Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study-Reference-Cited by-同舟云学术

Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study

Published:2024-02 Issue:2 Volume:25 Page:255-264
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Pfister Christian,Gravis Gwenaelle,Flechon Aude,Chevreau Christine,Mahammedi Hakim,Laguerre Brigitte,Guillot Aline,Joly Florence,Soulie Michel,Allory Yves,Harter Valentin,Culine Stéphane,PIGNOT Géraldine,FENDLER Jean Philippe,GUY Laurent,VERHOEST Grégory,MOTTET Nicolas,DOERFLER Arnaud,ABADIE LACOURTOISIE Sophie,AZZOUZI Abde Rahmene,MONGIAT Pierre,GEOFFROIS Lionnel,ESCHWEGE Pascal,DI FIORE Frédéric,ROUBAUD Guilhem,HOEPFFNER Jean Luc,BARTHELEMY Philippe,LANG Hervé,VOOG Eric,MANDRON Eric,TOURANI Jean Marc,SERRATE Camille,COLAU Alexandre,SALDANA Carolina,DE LA TAILLE Alexandre,NGUYEN Thierry,KLEINCLAUSS François,LORIOT Yohan,IRANI Jacques,EYMARD Jean Christophe,LARRE Stéphane,HUILLARD Olivier,ZERBIB Marc,ROLLAND Frédéric,RIGAUD Jérôme,HOUEDE Nadine,DROUPY Stéphane,MALOUF Georgina,ROUPRET Morgan,VIEILLOT Sabine,LETANG Nicolas,LHARIDON Tiffen,GASCHIGNARD Nicolas,HILGERS Werner,DAVIN Jean Louis

Funder

INCa

Publisher

Elsevier BV

Subject

Oncology

Reference34 articles.

1. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N Engl J Med,2003

2. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data;Eur Urol,2005

3. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial;Griffiths;J Clin Oncol,2011

4. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer;Alfred Witjes;Eur Urol,2017

5. Guideline on muscle-invasive and metastatic bladder cancer (European Association of Urology guideline): American Society of Clinical Oncology clinical practice guideline endorsement;Milowsky;J Clin Oncol,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative chemotherapy and immunotherapy to optimize cystectomy outcomes in the curative intent of non-metastatic muscle-invasive bladder cancer: A systematic review and meta-analysis;The French Journal of Urology;2024-09

2. Social Vulnerability and Receipt of Neoadjuvant Chemotherapy in Patients Undergoing Radical Cystectomy for Bladder Cancer;Urology;2024-09

3. Neue Systemtherapie beim fortgeschrittenen Harnblasenkarzinom;Die Urologie;2024-08-29

4. Kann beim muskelinvasiven Urothelkarzinom der Harnblase zukünftig auf die Zystektomie verzichtet werden?;Die Urologie;2024-08-14

5. A Multicenter, Single-Arm, Prospective Trial to Evaluate Efficacy and Safety of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Carboplatin (DD-MVACarbo) Chemotherapy for Cisplatin-Ineligible Patients with Advanced Urothelial Cancer: Study Protocol of the CARBUNCLE Trial;Methods and Protocols;2024-07-29